24 October 2024NewsAmericasMarisa Woutersen
Big Pharma counsel embrace AI but data and legal risks loom
Counsel from Pfizer, Gilead, and Bristol Myers Squibb spoke on AI’s transformative power and risks, reports Marisa Woutersen at LSPN Fall North America.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
17 October 2024 At LSPN Fall North America, in-house counsel offered guidance on how to nail the perfect patent application. Marisa Woutersen reports.
Americas
17 October 2024 As the pharma sector grapples with legal and regulatory upheaval, LSPN Fall North America explored the need for companies to reassess their patent strategies. Marisa Woutersen reports.
Americas
22 October 2024 In-house pharma and biotech lawyers are taking on broader roles, from handling regulatory issues to corporate strategy—and outside counsel can help, finds Marisa Woutersen.
Editor's picks
Editor's picks
Americas
17 October 2024 At LSPN Fall North America, in-house counsel offered guidance on how to nail the perfect patent application. Marisa Woutersen reports.
Americas
17 October 2024 As the pharma sector grapples with legal and regulatory upheaval, LSPN Fall North America explored the need for companies to reassess their patent strategies. Marisa Woutersen reports.
Americas
22 October 2024 In-house pharma and biotech lawyers are taking on broader roles, from handling regulatory issues to corporate strategy—and outside counsel can help, finds Marisa Woutersen.
Americas
17 October 2024 At LSPN Fall North America, in-house counsel offered guidance on how to nail the perfect patent application. Marisa Woutersen reports.
Americas
17 October 2024 As the pharma sector grapples with legal and regulatory upheaval, LSPN Fall North America explored the need for companies to reassess their patent strategies. Marisa Woutersen reports.
Americas
22 October 2024 In-house pharma and biotech lawyers are taking on broader roles, from handling regulatory issues to corporate strategy—and outside counsel can help, finds Marisa Woutersen.